1. Home
  2. ARTL vs BBGI Comparison

ARTL vs BBGI Comparison

Compare ARTL & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • BBGI
  • Stock Information
  • Founded
  • ARTL 2011
  • BBGI 1961
  • Country
  • ARTL United States
  • BBGI United States
  • Employees
  • ARTL N/A
  • BBGI N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • BBGI Broadcasting
  • Sector
  • ARTL Health Care
  • BBGI Consumer Discretionary
  • Exchange
  • ARTL Nasdaq
  • BBGI Nasdaq
  • Market Cap
  • ARTL 7.0M
  • BBGI 8.3M
  • IPO Year
  • ARTL N/A
  • BBGI 2000
  • Fundamental
  • Price
  • ARTL $5.47
  • BBGI $5.27
  • Analyst Decision
  • ARTL Buy
  • BBGI
  • Analyst Count
  • ARTL 2
  • BBGI 0
  • Target Price
  • ARTL $30.00
  • BBGI N/A
  • AVG Volume (30 Days)
  • ARTL 120.0K
  • BBGI 2.9K
  • Earning Date
  • ARTL 11-11-2025
  • BBGI 11-04-2025
  • Dividend Yield
  • ARTL N/A
  • BBGI N/A
  • EPS Growth
  • ARTL N/A
  • BBGI N/A
  • EPS
  • ARTL N/A
  • BBGI N/A
  • Revenue
  • ARTL N/A
  • BBGI $227,387,784.00
  • Revenue This Year
  • ARTL N/A
  • BBGI $5.02
  • Revenue Next Year
  • ARTL N/A
  • BBGI N/A
  • P/E Ratio
  • ARTL N/A
  • BBGI N/A
  • Revenue Growth
  • ARTL N/A
  • BBGI N/A
  • 52 Week Low
  • ARTL $4.20
  • BBGI $3.67
  • 52 Week High
  • ARTL $28.60
  • BBGI $14.95
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 33.32
  • BBGI 67.18
  • Support Level
  • ARTL $4.60
  • BBGI $4.55
  • Resistance Level
  • ARTL $5.75
  • BBGI $4.80
  • Average True Range (ATR)
  • ARTL 0.52
  • BBGI 0.12
  • MACD
  • ARTL -0.07
  • BBGI 0.07
  • Stochastic Oscillator
  • ARTL 24.52
  • BBGI 75.26

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

Share on Social Networks: